AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / CHEMICALS & ALLIED PRODUCTS
Balchem Corporation
XNAS · usd
SIC 2800 · CHEMICALS & ALLIED PRODUCTS
FIGI BBG001S5P2R4
177.00▲ 3.77 (2.18%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
173.23
Day's Range
173.09 – 177.45
52-Week Range
147.18 – 184.03
Volume
602.6K
Avg Volume
244.0K
Share Statistics
Shares Outstanding
Employees
1,352
Exchange
XNAS
Listed
1986-06-03
Share count as of October 15, 2026

Balchem Corporation (BCPC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Balchem Corporation (BCPC)
What is Balchem Corporation's Market Cap?
Balchem Corporation's Market Cap is $5.6B, based on as-reported figures from SEC (XBRL) filings.
What is Balchem Corporation's Enterprise Value?
Balchem Corporation's Enterprise Value is $5.6B, based on as-reported figures from SEC (XBRL) filings.
What is Balchem Corporation's Trailing P/E?
Balchem Corporation's Trailing P/E is 32.9×, based on as-reported figures from SEC (XBRL) filings.
What is Balchem Corporation's Price / Sales?
Balchem Corporation's Price / Sales is 5.1×, based on as-reported figures from SEC (XBRL) filings.
What is Balchem Corporation's EV / Revenue?
Balchem Corporation's EV / Revenue is 5.0×, based on as-reported figures from SEC (XBRL) filings.
What is Balchem Corporation's EV / EBITDA?
Balchem Corporation's EV / EBITDA is 20.0×, based on as-reported figures from SEC (XBRL) filings.
What is Balchem Corporation's Revenue (TTM)?
Balchem Corporation's Revenue (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Balchem Corporation's Net Income (TTM)?
Balchem Corporation's Net Income (TTM) is $170.9M, based on as-reported figures from SEC (XBRL) filings.
What is Balchem Corporation's EBITDA?
Balchem Corporation's EBITDA is $278.4M, based on as-reported figures from SEC (XBRL) filings.
What is Balchem Corporation's Diluted EPS (TTM)?
Balchem Corporation's Diluted EPS (TTM) is 5.38, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BCPCAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Net sales
YoY growth+8.6%+11.2%+8.1%+9.8%
Cost of sales
Gross margin
% of revenue36.4%36.5%37.3%35.6%
Operating expenses:
Selling expenses
Research and development expenses
General and administrative expenses
Total operating expenses
% of revenue14.9%15.7%16.8%15.8%
Earnings from operations
% of revenue21.5%20.9%20.5%19.8%
Other expenses, net:
Interest expense, net
Other expense (income), net
Total other (income) expenses
Earnings before income tax expense
Income tax expense
Net earnings
% of revenue16.1%15.7%14.9%14.9%
Net earnings per common share - basic (in dollars per share)—
Net earnings per common share - diluted (in dollars per share)—